{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-043210","form_type":"8-K","ticker":"RMTI","cik":"0001041024","company_name":"ROCKWELL MEDICAL, INC.","filed_at":"2026-06-15T20:27:59+00:00","discovered_at":"2026-06-15T20:29:00.311848+00:00","generated_at":"2026-06-15T20:32:19.601523+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Rockwell Medical stockholders approve reverse stock split, elect directors","bullets":["Reverse stock split amendment approved: 16,993,038 for, 6,597,036 against, 223,632 abstain.","Class II directors Joseph Dawson and Joan Lau reelected with 9.8M and 9.9M votes for, respectively.","Advisory vote on executive compensation passed: 8,232,918 for, 2,682,354 against, 96,595 abstain.","Ratification of EisnerAmper LLP as auditor for 2026 approved: 22,996,530 for, 698,744 against.","Reverse stock split intended to regain compliance with Nasdaq minimum bid price requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-043210","json":"https://secwatch.observer/filing/0001628280-26-043210.json","markdown":"https://secwatch.observer/filing/0001628280-26-043210.md","text":"https://secwatch.observer/filing/0001628280-26-043210.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/rmti-20260612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T20:32:19.601523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1cc16c4bb6d59c3f4f8307c863c10fec64830127","claim":"ROCKWELL MEDICAL, INC. shareholders approved To elect the two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified. at the 2026-06-12 meeting.","evidence_excerpt":"Proposal One: To elect the two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified. For Against Abstain Broker Non-Votes Joseph Dawson 9,812,114 869,022 330,731 12,801,839 Joan Lau, Ph.D. 9,890,379 729,615 391,873 12,801,839","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-12"}],"fact_type":"shareholder_vote"},{"claim_id":"7c4fbc4eae997ae3e1bd360ff85e67048f5ce51b","claim":"ROCKWELL MEDICAL, INC. shareholders approved To approve and adopt an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock. at the 2026-06-12 meeting.","evidence_excerpt":"Proposal Four: To approve and adopt an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock. For Against Abstain 16,993,038 6,597,036 223,632","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-12"}],"fact_type":"shareholder_vote"},{"claim_id":"957e21513dd0f834e95ade4e18398afff260595f","claim":"ROCKWELL MEDICAL, INC. shareholders approved To ratify the selection of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2026. at the 2026-06-12 meeting.","evidence_excerpt":"Proposal Three: To ratify the selection of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2026. For Against Abstain 22,996,530 698,744 118,432","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-12"}],"fact_type":"shareholder_vote"},{"claim_id":"ca718b00c23cba727fb6a913721f50efd12e81ac","claim":"ROCKWELL MEDICAL, INC. shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers. at the 2026-06-12 meeting.","evidence_excerpt":"Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers. For Against Abstain Broker Non-Votes 8,232,918 2,682,354 96,595 12,801,839","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-12"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}